Cybin Inc. (HELP)
NASDAQ: HELP · Real-Time Price · USD
7.10
+0.34 (5.03%)
Feb 18, 2026, 4:00 PM EST - Market closed
Cybin Employees
Cybin had 50 employees as of March 31, 2025. The number of employees did not change compared to the previous year.
Employees
50
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,464,346
Market Cap
355.25M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 50 | 0 | - |
| Mar 31, 2024 | 50 | 0 | - |
| Mar 31, 2023 | 50 | 0 | - |
| Mar 31, 2022 | 50 | 12 | 31.58% |
| Mar 31, 2021 | 38 | 37 | 3,700.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| Bicycle Therapeutics | 305 |
| Rocket Pharmaceuticals | 299 |
| Nautilus Biotechnology | 124 |
| Adlai Nortye | 123 |
| Aclaris Therapeutics | 64 |
| Atea Pharmaceuticals | 56 |
| Protara Therapeutics | 33 |
HELP News
- 1 day ago - Nature Medicine Publishes Helus Pharma's Randomized, Placebo-Controlled Phase 2a Trial of SPL026 in Major Depressive Disorder - GlobeNewsWire
- 5 days ago - HELUS Pharma Reports Third Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights - GlobeNewsWire
- 7 weeks ago - Cybin Initiates At-The-Market Equity Program of up to US$100 Million - Business Wire
- 2 months ago - Cybin to Transfer U.S. Stock Exchange Listing to Nasdaq - Business Wire
- 3 months ago - Cybin Inc. (CYBN) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Cybin Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights - Business Wire
- 3 months ago - Cybin to Participate in the Jefferies Global Healthcare Conference in London - Business Wire
- 3 months ago - Cybin to Announce Second Quarter Financial Results and Provide Business Update on November 13, 2025 - Business Wire